Clinical trial
Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy…
NCT00183846 · University of Southern California, Other · Completed
Key facts
| NCT number | NCT00183846 |
|---|---|
| Title | Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers |
| Official title | Phase I Study of Irinotecan Administered as a Continuous Infusion and Radiation Therapy for Upper Gastrointestinal Cancers |
| Lead sponsor | University of Southern California, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer, Gastric Cancer, Duodenum Cancer, Bile Duct Cancer |
| Intervention type | Drug, Procedure |
| Interventions | irinotecan, radiation therapy |
| Enrollment | 22 |
| Start date | Dec 1, 2000 |
| Primary completion | Oct 1, 2007 |
| Completion | Jul 1, 2009 |
| First posted | Sep 16, 2005 |
| Last update posted | May 22, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: